| ATC Codes | Pharmacological Classification | Pharmacological Classification/DDD |
|---|---|---|
| L | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS | 抗肿瘤药和免疫机能调节药 |
| L01 | ANTINEOPLASTIC AGENTS | 抗肿瘤药 |
| L01X | OTHER ANTINEOPLASTIC AGENTS | 其它抗肿瘤药物 |
| L01XC | Monoclonal antibodies | 单克隆抗体类 |
| L01XC01 | edrecolomab | 依决洛单抗 |
| L01XC02 | rituximab | 利妥昔单抗 |
| L01XC03 | trastuzumab | 曲妥珠单抗 |
| L01XC05 | gemtuzumab | 吉妥珠单抗 |
| L01XC06 | cetuximab | 塞妥昔单抗 |
| L01XC07 | bevacizumab | 贝伐珠单抗 |
| L01XC08 | panitumumab | 帕尼姆单抗 |
| L01XC09 | catumaxomab | 卡妥索单抗 |
| L01XC10 | ofatumumab | |
| L01XC13 | pertuzumab | 帕妥珠单抗 |
| L01XC14 | trastuzumab emtansine | 曲妥珠单抗 |
| L01XC17 | nivolumab | 尼沃鲁单抗 |
| L01XC18 | pembrolizumab | 兰洛利珠单抗 |
| L01XC19 | blinatumomab | 布利妥莫单抗 |
| L01XC21 | ramucirumab | 雷姆赛卢单抗 |
| L01XC22 | necitumumab | 奈西妥木单抗 |